Professional Documents
Culture Documents
Abstract Hnatiuc Mycobacteria v2 PDF
Abstract Hnatiuc Mycobacteria v2 PDF
Abstract Hnatiuc Mycobacteria v2 PDF
future
applications” & MP1101 Biomedical Applications of Atmospheric Pressure Plasma Technology, Bertinoro, Italy, 13th-17th September 2015
Mycobacteria are still important agents of humans and animals infections. The major pathogen
is Mycobacterium tuberculosis (MTB) that infects almost 1.5 billion people and kills 1.3 million
people each year [1].
The aim of this study was to evaluate the mycobacteria disinfection efficacy of plasma activated
water obtained by the activation of water with GlidArc reactor and explore its mechanism of
action. The experiment was performed on M. tuberculosis K37Ra, Lehmann and Neumann
(ATCC 25177), M. avium subsp. avium (CECT 7407), M. smegmatis (CECT 3017), M. marinum
(CECT 7091), M. abscessus (CECT 8517), M. chelonae (CECT 8519), M. kansasii (CECT
3030), M. peregrinum (CECT 3023), strains subcultured in Middlebrook 7H9 broth and plated on
8
Löwenstein Jensen (LJ) medium. Suspensions of mycobacteria (10 CFU/mL) were treated by
plasma-activated water (PAW) for different period of time (5, 10, 15, 20, and 30 minutes).
The reduction of mycobacterial burden was evaluated using colony-forming unit (CFU) count
and the formula: log10 (No. CFU before PAW treatment / No. CFU after PAW treatment). In
order to assess the impact of PAW treatment on mycobacterial structure, scanning electron
microscopy (SEM) was used. The integrity of the cell membranes was investigated by UV
spectrophotometry. In addition, X-ray photoelectron spectroscopy (XPS) and Fourier Transform
Infrared Spectrometry (FT-IR) were used to study the interaction of PAW with cell wall of
mycobacteria.
A reduction higher than 5 logarithmic units was observed after an exposure time of 15-min, that
means a powerful mycobactericidal effect. After an exposure time of 20-min, the complete
inactivation of mycobacteria was achieved (sterilization).
[1] World Health Organization. Global Tuberculosis Control: WHO Report 2013 (WHO, Geneva, 2013).
[2] G. McDonnell, AD. Russell , Clin. Microbiol. Rev. 12 (1999) 147–179.
[3] M. Ursache, R. Moraru, V. Nastasa, E. Hnatiuc and M. Mares, International Conference on Optimization of
Electrical and Electronic Equipment (OPTIM) (2014), 1036-104.
[4] U. K. Ercan, H. Wang, J. Haifeng, G. Freidman. A.D. Brooks and G.J. Suresh, Plasma Processes and Polymers,
10, (2013) 544-555.